AELIX Therapeutics Revenue and Competitors

Barcelona, Spain

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AELIX Therapeutics's estimated annual revenue is currently $1.7M per year.(i)
  • AELIX Therapeutics's estimated revenue per employee is $155,000

Employee Data

  • AELIX Therapeutics has 11 Employees.(i)
  • AELIX Therapeutics grew their employee count by -8% last year.

AELIX Therapeutics's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.4M41N/AN/AN/A
#2
$0.9M6N/AN/AN/A
#3
$5.9M38N/AN/AN/A
#4
$47M30318%N/AN/A
#5
$9.5M6111%N/AN/A
#6
$46.7M30125%N/AN/A
#7
$1.7M11-8%N/AN/A
#8
$3.7M24-11%N/AN/A
#9
$4.2M2713%N/AN/A
#10
$5.3M346%N/AN/A
Add Company

What Is AELIX Therapeutics?

AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen.

keywords:N/A

N/A

Total Funding

11

Number of Employees

$1.7M

Revenue (est)

-8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M11-15%N/A
#2
$1.7M11-27%N/A
#3
$1M11N/AN/A
#4
$1M11-48%N/A
#5
$1.4M11-27%N/A